Acquired by Green Shield last week, the Rouyn-Noranda-based firm champions employee assistance programs, despite their l
Biologics are putting a strain on private group plans by treating orphan diseases, as well as common diseases, at high c
GSC is banking on its fully integrated platform and increased presence in Quebec to achieve this goal.
“The question we were trying to answer was if clinicians are provided access to pharmacogenomic test results during rout
A new pharmacogenomic clinical trial study has confirmed the value of tailoring drug treatment to a person’s genetic mak
Green Shield Canada has announced a fraud prevention and detection strategy centred on artificial intelligence and house